Intervention Review

Botulinum toxin injections for the treatment of spasmodic dysphonia

  1. Christopher Watts1,*,
  2. Renata Whurr2,
  3. Chad Nye3

Editorial Group: Cochrane Ear, Nose and Throat Disorders Group

Published Online: 20 JAN 2010

Assessed as up-to-date: 21 JUL 2009

DOI: 10.1002/14651858.CD004327.pub2

Database Title

Additional Information

How to Cite

Watts C, Whurr R, Nye C. Botulinum toxin injections for the treatment of spasmodic dysphonia. Cochrane Database of Systematic Reviews 2004, Issue 3. Art. No.: CD004327. DOI: 10.1002/14651858.CD004327.pub2.

Author Information

  1. 1

    Texas Christian University, Department of Communication Sciences and Disorders, Fort Worth, Texas, USA

  2. 2

    The National Hospital for Neurology and Neurosurgery, Therapies Services, London, UK

  3. 3

    University of Central Florida, UCF CARD Center, Orlando, Florida, USA

*Christopher Watts, Department of Communication Sciences and Disorders, Texas Christian University, TCU Box 297450, Fort Worth, Texas, TX 76129, USA. c.watts@tcu.edu.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 20 JAN 2010

SEARCH

ARTICLE TOOLS

View Full Article (HTML) Summary (57K)Standard (231K)Full (270K)

  1. Current Version

    Botulinum toxin injections for the treatment of spasmodic dysphonia

    Christopher Watts, Renata Whurr and Chad Nye

    Article first published online: 20 JAN 2010 | DOI: 10.1002/14651858.CD004327.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Botulinum toxin for spasmodic dysphonia

    C Watts, R Whurr and C Nye

    Article first published online: 21 JUL 2003 | DOI: 10.1002/14651858.CD004327

View Full Article (HTML) Summary (57K)Standard (231K)Full (270K)